All subjects receive tirzepatide at the maximally tolerated dose for 36 weeks
Reference values for e-GST activity in all these mammals have been determined
Fuel is: Non-habit forming Functional (not just symptomatic) Gut-brain connected Gentle enough to use daily No brute force
Obesity has been implicated as promoting cardiovascular disease, diabetes, hypertension, and other complications, suggesting that sustained, effective weight loss may have independent cardiovascular benefit [13] [14]
MacDonald-Ramos, K., Michn, L., Martnez-Ibarra, A., & Cerbn, M
Shortland GJ, Walter JH, Stroud C, Fleming PJ, Speidel BD, Marlow N